Denali Therapeutics

5 followers

‌

Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families.

Industries

Employees

201-500

Links

Org chart

Ryan Watts

Collapse
Alex Schuth
Chief Operating And Financial Officer
Carole Ho
Chief Medical Officer And Head Of Development
Dana Andersen
Chief Technical & Manufacturing Officer
Cindy Dunkle
Chief People Officer
Joe Lewcock
Chief Scientific Officer
Katie Peng
Chief Commercial Officer
Chris Walsh
General Counsel
Cynthia Wong
Senior Vice President, Portfolio Planning & Program Management
Michelle Polowski
SVP, Development Operations
Kirk Henne
SVP, Development Sciences
Mark Rowen
VP, Corporate Development
Fabian Model
VP, Biometrics
Wei Dong
VP, Drug Safety
Chris Koth
VP, Discovery Sciences
Sarah Martin
VP, U.S. ETV Franchise & Global Product Strategy
Naim Nazef
VP, Oligonucleotide Therapeutics
Firoz Antia
VP, Oligonucleotide & Small Molecule CMC
Michael Ostland
Head Of Development Europe